COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
BB Biotech Q2 2025: outperforms Nasdaq Biotech Index; strong USD returns, currency drag in CHF
BB Biotech AG outperforms Nasdaq Biotech Index in Q2 2025, with strong USD returns but currency drag in CHF. Strategic acquisitions and advancements in portfolio companies drive innovation and value creation -
-
COMMUNIQUÉ DE PRESSE
FORVIA HELLA presents half-year results for 2025: Sales at previous year's level, largely stable earnings development; outlook is confirmed
FORVIA HELLA presents 2025 half-year results: sales stable, earnings improve; outlook confirmed. Group sales €4.0 billion, operating income margin 6.0 percent -
-
COMMUNIQUÉ DE PRESSE
Significant increase in sales and higher operating result in the first half of the year due to the growing ventilation segment
Zehnder Group AG reports 11% increase in sales and 45% rise in operating result for the first half of 2025 driven by growth in ventilation segment. Forecast for full year 2025 provided
